TY - JOUR
T1 - Prognostic value of leaflet coaptation gap in transcatheter edge-to-edge repair for functional mitral regurgitation
AU - OCEAN-Mitral Investigators
AU - Nishiura, Naoki
AU - Kubo, Shunsuke
AU - Ono, Sachiyo
AU - Mushiake, Kazunori
AU - Osakada, Kohei
AU - Maruo, Takeshi
AU - Kadota, Kazushige
AU - Yamamoto, Masanori
AU - Saji, Mike
AU - Izumi, Yuki
AU - Asami, Masahiko
AU - Enta, Yusuke
AU - Shirai, Shinichi
AU - Izumo, Masaki
AU - Mizuno, Shingo
AU - Watanabe, Yusuke
AU - Amaki, Makoto
AU - Kodama, Kazuhisa
AU - Yamaguchi, Junichi
AU - Naganuma, Toru
AU - Bota, Hiroki
AU - Ohno, Yohei
AU - Hachinohe, Daisuke
AU - Yamawaki, Masahiro
AU - Ueno, Hiroshi
AU - Mizutani, Kazuki
AU - Otsuka, Toshiaki
AU - Hayashida, Kentaro
AU - Tanaka, Makoto
AU - Tsuruta, Hikaru
AU - Saito, Tetsuya
AU - Kobari, Yusuke
AU - Ryuzaki, Toshinobu
AU - Takahashi, Tatsuo
AU - Goto, Shinichi
AU - Imaeda, Shohei
AU - Sakata, Shingo
AU - Katsumata, Yoshinori
AU - Shirakawa, Kohsuke
AU - Iwata, Juri
AU - Shinada, Keitaro
AU - Kajino, Akiyoshi
AU - Kato, Jungo
AU - Arita, Ryo
AU - Moriizumi, Tomonari
AU - Sago, Mitsuru
AU - Tsunaki, Tatsuya
AU - Yamaguchi, Ryo
AU - Yanagisawa, Junji
AU - Tanaka, Shuhei
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2025.
PY - 2025
Y1 - 2025
N2 - Background Coaptation gap (CG) is one of the challenging anatomies of mitral transcatheter edge-to-edge repair (TEER), but its impact on patient outcomes is unclear. This study aimed to evaluate the impact of CG on procedural and clinical outcomes in patients with functional mitral regurgitation (MR). Methods Data from 2140 patients undergoing TEER for functional MR were analysed, focusing on the presence of CG, which is a missing leaflet coaptation between the anterior and posterior leaflets during systole. The primary outcome was a composite of death, heart failure hospitalisation and mitral valve reintervention. Results Of the 2140 patients, 219 (10%) had CG and 1921 (90%) did not, as assessed by baseline transoesophageal echocardiography. In patients with CG, baseline MR grade and New York Heart Association (NYHA) functional class were more severe, and long/wide clip types were used more frequently. Post-TEER, patients with CG had significantly lower achievement of MR grade ≤2+ (93%) and ≤1+ (65%) compared with patients without CG (97%, p<0.01; 82%, p<0.01, respectively). NYHA functional class at 1 year was similar in both groups. The cumulative incidence of the primary outcome was comparable between CG and non-CG groups (51% vs 53% at 3 years, p=0.71). While residual MR grade 2+ was associated with the higher primary outcome incidence compared with ≤1+ in patients without CG (p<0.01), no significant difference was found in patients with CG (p=0.51). Conclusion CG was associated with less MR reduction but with no clear difference in adverse clinical outcomes after TEER. Similar outcomes between residual MR grade 2+ and ≤1+ in CG patients highlight the importance of procedural endpoint in anatomically challenging cases.
AB - Background Coaptation gap (CG) is one of the challenging anatomies of mitral transcatheter edge-to-edge repair (TEER), but its impact on patient outcomes is unclear. This study aimed to evaluate the impact of CG on procedural and clinical outcomes in patients with functional mitral regurgitation (MR). Methods Data from 2140 patients undergoing TEER for functional MR were analysed, focusing on the presence of CG, which is a missing leaflet coaptation between the anterior and posterior leaflets during systole. The primary outcome was a composite of death, heart failure hospitalisation and mitral valve reintervention. Results Of the 2140 patients, 219 (10%) had CG and 1921 (90%) did not, as assessed by baseline transoesophageal echocardiography. In patients with CG, baseline MR grade and New York Heart Association (NYHA) functional class were more severe, and long/wide clip types were used more frequently. Post-TEER, patients with CG had significantly lower achievement of MR grade ≤2+ (93%) and ≤1+ (65%) compared with patients without CG (97%, p<0.01; 82%, p<0.01, respectively). NYHA functional class at 1 year was similar in both groups. The cumulative incidence of the primary outcome was comparable between CG and non-CG groups (51% vs 53% at 3 years, p=0.71). While residual MR grade 2+ was associated with the higher primary outcome incidence compared with ≤1+ in patients without CG (p<0.01), no significant difference was found in patients with CG (p=0.51). Conclusion CG was associated with less MR reduction but with no clear difference in adverse clinical outcomes after TEER. Similar outcomes between residual MR grade 2+ and ≤1+ in CG patients highlight the importance of procedural endpoint in anatomically challenging cases.
KW - Mitral Valve Insufficiency
UR - https://www.scopus.com/pages/publications/105015766030
U2 - 10.1136/heartjnl-2024-325585
DO - 10.1136/heartjnl-2024-325585
M3 - 学術論文
C2 - 40921461
AN - SCOPUS:105015766030
SN - 1355-6037
JO - Heart
JF - Heart
ER -